EUVIMEDEUVIMED entdecken
Open Access

Screening Natriuretic Peptide Levels Predicts Heart Failure and Death in Individuals With Type 1 and Type 2 Diabetes Without Known Heart Failure

Rodica Pop-Busui iD, Enrico Repetto, Jason Baron, Dagmar Schumacher, Muthiah Vaduganathan iD, Ambarish Pandey

Diabetes Care · 2025

DOI: 10.2337/dc25-1260 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Care, 2025. Verfasst von Rodica Pop-Busui und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes, and Clinical Nutrition, Oregon Health and Science University, Portland, OR. Hauptthemen laut MEDLINE: Heart Failure, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Natriuretic Peptide, Brain. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Roche Diagnostics, NIMHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Heart failure (HF) is common in diabetes and may be asymptomatic in early stages. N-terminal pro-brain natriuretic peptide (NT-proBNP) and B-type natriuretic peptide (BNP) (collectively natriuretic peptides [NPs]) are markers that can be used to detect early HF in asymptomatic individuals who may benefit from disease-modifying therapies. We examined the prognostic role of NP levels in people with type 1 diabetes (T1D) or type 2 diabetes (T2D) without known HF. RESEARCH DESIGN AND METHODS Optum’s de-identified Market Clarity Data were queried for adults (aged ≥18 years) with T1D or T2D without known HF who received an outpatient NP test between 2017 and 2023. Associations between NP levels and incident HF or death were assessed using multivariable Cox proportional hazard models. RESULTS Among 116,466 eligible adults (n = 2,990 with T1D; n = 113,476 with T2D) followed for up to 7 years (54% female; median age 64 years; mean HbA1c 7.1% at baseline), approximately 39.6% of individuals with T1D and 42.3% of individuals with T2D had BNP ≥50 pg/mL or NT-proBNP ≥125 pg/mL. In adjusted Cox models, increased NT-proBNP level was significantly associated with increased risk of incident HF or mortality among individuals with T1D (for NT-proBNP level 125–300 pg/mL: HR [95% CI] 2.04 [1.35–3.07], for NT-proBNP level >300 pg/mL: 4.48 [3.11–6.47], reference: NT-proBNP <125 pg/mL) and T2D (for NT-proBNP level 125–300 pg/mL: HR [95% CI] 1.85 [1.74–1.97], for NT-proBNP >300 pg/mL: 3.58 [3.39–3.78], reference: NT-proBNP <125 pg/mL). Similar findings were observed for BNP. CONCLUSIONS Increased NP levels among individuals with diabetes are highly prognostic for future risk of HF or mortality. These findings support the implementation of NP screening for HF risk assessment in people with diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Natriuretic Peptide, BrainNatriuretic PeptidesHumansFemaleMaleMiddle AgedAgedAdultPeptide FragmentsBiomarkersPrognosis

Substanzen

Natriuretic Peptide, BrainPeptide Fragmentspro-brain natriuretic peptide (1-76)BiomarkersNatriuretic Peptides

Autor:innen und Institutionen

  • Division of Endocrinology, Diabetes, and Clinical Nutrition, Oregon Health and Science University, Portland, OR.
  • Department of Internal Medicine, University of Michigan, Ann Arbor, MI.
  • Roche Diagnostics Corporation, Indianapolis, IN.
  • Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
  • Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX.

ORCID-Profile: Rodica Pop-Busui, Muthiah Vaduganathan

Förderung

  • NIDDK NIH HHS
  • Roche Diagnostics
  • NIMHD NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Pop-Busui, R., Repetto, E., Baron, J., Schumacher, D., Vaduganathan, M., & Pandey, A. (2025). Screening Natriuretic Peptide Levels Predicts Heart Failure and Death in Individuals With Type 1 and Type 2 Diabetes Without Known Heart Failure. Diabetes Care. https://doi.org/10.2337/dc25-1260

Vancouver

Pop-Busui R, Repetto E, Baron J, Schumacher D, Vaduganathan M, Pandey A. Screening Natriuretic Peptide Levels Predicts Heart Failure and Death in Individuals With Type 1 and Type 2 Diabetes Without Known Heart Failure. Diabetes Care. 2025. doi:10.2337/dc25-1260

BibTeX
@article{PopBusui2025,
  author = {Pop-Busui, Rodica and Repetto, Enrico and Baron, Jason and Schumacher, Dagmar and Vaduganathan, Muthiah and Pandey, Ambarish},
  title = {Screening Natriuretic Peptide Levels Predicts Heart Failure and Death in Individuals With Type 1 and Type 2 Diabetes Without Known Heart Failure},
  journal = {Diabetes Care},
  year = {2025},
  doi = {10.2337/dc25-1260}
}
Kostenlos starten →